中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共9条，第1-9条

帮助

条数/页：排序方式：
	Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers 期刊论文 OAI收割 CLINICAL THERAPEUTICS, 2021, 卷号: 43, 期号: 9, 页码: E264-E273 作者: Chen, Zhen-dong; Chen, Qian; Zhu, Yun-ting; Zhang, Yi-fan; Zhan, Yan \| 收藏 \| 浏览/下载：46/0 \| 提交时间：2022/01/04 henagliflozin food effects mass balance pharmacokinetics SGLT-2 inhibitor
	Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure 期刊论文 OAI收割 JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 卷号: 10, 期号: 6, 页码: 33 作者: Li, Xuan; Lu, Qingguo; Qiu, Yunguang; do Carmo, Jussara M.; Wang, Zhen \| 收藏 \| 浏览/下载：22/0 \| 提交时间：2021/05/24 cardiac hypertrophy cardiac metabolism cardiomyocytes sodium glucose cotransporter 2 transverse aortic constriction
	Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration 期刊论文 OAI收割 CLINICAL THERAPEUTICS, 2021, 卷号: 43, 期号: 2, 页码: 396-409 作者: Zhang, Yi-fan; Liu, Yan-mei; Yu, Chen; Wang, Ya-ting; Zhan, Yan \| 收藏 \| 浏览/下载：23/0 \| 提交时间：2021/05/24 diabetes henagliflozin pharmacodynamics pharmacokinetics SGLT-2 inhibitors
	Characterization and quantitative determination of henagliflozin metabolites in humans 期刊论文 OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 卷号: 192, 页码: 8 作者: Chen, Zhendong; Li, Liang; Zhan, Yan; Zhang, Yifan; Liu, Haiyan \| 收藏 \| 浏览/下载：18/0 \| 提交时间：2021/05/24 Henagliflozin Metabolism LC-MS/MS
	Design, synthesis and biological evaluation of 6-deoxy O-spiroketal C-arylglucosides as novel renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes 期刊论文 OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 180, 页码: 398-416 作者: Wang, Yibing; Lou, Yang; Wang, Jiang; Li, Dan; Chen, Hui \| 收藏 \| 浏览/下载：25/0 \| 提交时间：2020/07/01 SGLT2 inhibitors Diabetes Sugar modification Structure-activity relationship Urinary glucose excretion Oral glucose tolerance
	Postnatal developmental changes of the small intestinal villus height, crypt depth and hexose transporter mrna expression in supplemental feeding and grazing goats 期刊论文 iSwitch采集 Small ruminant research, 2016, 卷号: 141, 页码: 106-112 作者: Li, Hengzhi; Ran, Tao; He, Zhixiong; Yan, Qiongxian; Tang, Shaoxun 收藏 \| 浏览/下载：45/0 \| 提交时间：2019/05/09 Villus Crypt Hexose transporter Intestine Feeding regime Goat
	SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models 期刊论文 OAI收割 ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 5, 页码: 613-624 作者: Yan, Pang-ke; Zhang, Li-na; Feng, Ying; Qu, Hui; Qin, Li \| 收藏 \| 浏览/下载：29/0 \| 提交时间：2019/01/08 sodium glucose cotransporter 2 (SGLT2) SHR3824 dapagliflozin type 2 diabetes mellitus blood glucose insulin sensitivity beta-cell function
	shr3824anovelselectiveinhibitorofrenalsodiumglucosecotransporter2exhibitsantidiabeticefficacyinrodentmodels 期刊论文 OAI收割 actapharmacologicasinica, 2014, 卷号: 35, 期号: 5, 页码: 613 作者: Yan Pangke; Zhang Lina; Feng Ying; Qu Hui; Qin Li \| 收藏 \| 浏览/下载：7/0 \| 提交时间：2020/07/01 BETA-CELL DIFFERENTIATION IMPROVES GLYCEMIC CONTROL TYPE-2 DIABETES-MELLITUS CHRONIC HYPERGLYCEMIA INSULIN-SECRETION SGLT-2 INHIBITOR SKELETAL-MUSCLE RATS DAPAGLIFLOZIN EMPAGLIFLOZIN sodium glucose cotransporter 2 (SGLT2) SHR3824 dapagliflozin type 2 diabetes mellitus blood glucose insulin sensitivity beta-cell function
	O-spiro c-aryl glucosides as novel sodium-dependent glucose co-transporter 2 (sglt2) inhibitors 期刊论文 iSwitch采集 Bioorganic & medicinal chemistry letters, 2009, 卷号: 19, 期号: 19, 页码: 5632-5635 作者: Xu, Baihua; Lv, Binhua; Feng, Yan; Xu, Ge; Du, Jiyan 收藏 \| 浏览/下载：25/0 \| 提交时间：2019/05/10 Sglt Spiro Glucosides